FDA.reportPublic FDA data

Ondansetron Hydrochloride

Product NDC
68071-4966
11-digit product format
680714966
Labeler code
68071
Product ID
68071-4966_1b2e68f9-41a8-bd88-e063-6294a90a08b5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ondansetron Hydrochloride
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
NUCARE PHARMACEUTICALS INC
Application
ANDA078539
Marketing category
ANDA
Marketing start
2007-07-31
Substance
ONDANSETRON HYDROCHLORIDE
Active strength
8 mg/1
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Ondansetron Hydrochloride
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ONDANSETRON HYDROCHLORIDE8 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiNMH84OZK2B
Rxcui312086

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d9bd4853-037c-6968-f4d4-9bb9a0efd1eaProduct name220250722
32e23bc9-ce14-4555-bb6d-bcb654d7d296Product name120201015
e459f50a-1553-4aab-b6bd-1e5f0c211c49Product name120201015
909480fe-0d18-c1c1-a658-0bd9a7131822Product name520170829

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
68071-4966-42024-06-18C16284748780-1ba0f9c33-1d84-a910-e053-dadaa90a0b85These highlights do not include all the information needed to use ONDANSETRON TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS. ONDANSETRON tablets, for oral use Initial U.S. Approval: 1991
68071-4966-42023-01-30C16284748780-1ba0f9c33-1d84-a910-e053-dadaa90a0b85These highlights do not include all the information needed to use ONDANSETRON TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS. ONDANSETRON tablets, for oral use Initial U.S. Approval: 1991
68071-4966-42021-02-18C16284748780-1ba0f9c33-1d84-a910-e053-dadaa90a0b85These highlights do not include all the information needed to use ONDANSETRON TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS. ONDANSETRON tablets, for oral use Initial U.S. Approval: 1991
68071-4966-42021-01-29C16284748780-1ba0f9c33-1d84-a910-e053-dadaa90a0b85These highlights do not include all the information needed to use ONDANSETRON TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS. ONDANSETRON tablets, for oral use Initial U.S. Approval: 1991

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68071-4966-4Ondansetron Hydrochloride4 in 1 BOTTLETABLET, FILM COATED43

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68071-4966ONDANSETRON HYDROCHLORIDE TABLET, FILM COATED [NUCARE PHARMACEUTICALS INC]3Current NDC, Legacy NDC, 1 package rows20240619_8d696b8c-eba6-505e-e053-2995a90acb5d.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
312086ondansetron HCl 8 MG Oral TabletPSN8d696b8c-eba6-505e-e053-2995a90acb5d3
312086ondansetron 8 MG Oral TabletSCD8d696b8c-eba6-505e-e053-2995a90acb5d3
312086ondansetron 8 MG (as ondansetron HCl dihydrate 10 MG) Oral TabletSY8d696b8c-eba6-505e-e053-2995a90acb5d3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
68071-4966-4680714966044 TABLET, FILM COATED in 1 BOTTLE (68071-4966-4) 2019-07-110000-00-00NoNoCurrent